Canaccord Genuity maintains Buy on AngioDynamics; $20 target
Canaccord Genuity kept its Buy rating on AngioDynamics and reiterated a $20.00 price target, implying 78.1% upside versus the Oct 8 close of $11.23.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.